Agilent developing new applications for mass spectrometry system

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Tsyhun)
(Image: iStock/Tsyhun)

Related tags: Science, Contract, Toxicology

Agilent Technologies has contracted the original creators of its RapidFire 365 High-throughput Mass Spectrometry System to further develop new applications.

Can Özbal, PureHoney Technologies president and CEO and his team were the principals of BIOCIUS Life Sciences before it was acquired by Agilent in 2011, and with it, the RapidFire technology.

The employees worked as part of Agilent until 2014 before leaving nearly two years ago to start their “new venture​” based around the technology as a CRO, Özbal told us.

You can buy the instruments from Agilent, but you can also outsource experiments to PureHoney as a contract research business​,” he said.

Once again working with Agilent, Özbal expalined the collaboration should be “very successful​.”

We have a different corporate structure, but the connections are there, and are very strong and deep​,” he added. “We’re very excited to be working with Agilent again​.”

The tool was originally developed for label-free high-throughput screening. Today, RapidFire/MS is used in applications ranging from ADME-Tox, proteomics, metabolomics, clinical research to in vivo functional assays.

Through the co-marketing agreement, PureHoney Technologies and RapidFire MS instrumentation will work to develop new workflows for pharma and biopharma research, in addition to forensic toxicology and metabolomics analysis. 

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us

Products

View more

Webinars